At FingerPost we support the leaders of BioTech and Pharmaceutical companies by providing market access and pricing strategy, insight and research. This support is critical when making investment decisions during asset development.

Our experience of launching products across multiple disease areas and multiple geographies means we understand the challenges surrounding launch from a range of perspectives.

To address the challenges and enable successful launches, exit strategies and asset acquisition we have identified a suite of solutions.

These solutions encompass a range of capabilities covering Phase II design through to launch execution.

Our team are also happy to provide ad-hoc advice and research to help solve issues and address key questions at any stage of clinical development.

As your strategic partner, we will help you to manage expectations internally, make appropriate investment decisions and achieve the best possible outcomes at launch.